See our latest analysis for OMRON.
Shares of OMRON have struggled for momentum this year, with the stock’s 1-year total shareholder return down 24.7 percent. Recent volatility reflects shifting sentiment around industrial automation demand. This year’s double-digit declines also highlight ongoing uncertainty about longer-term growth and company valuation.
If you’re rethinking your watchlist after these moves, now’s a smart time to discover fast growing stocks with high insider ownership.
With shares still trading well below analyst price targets despite some recent growth in revenue and net income, the question is whether OMRON now represents an undervalued opportunity or if the market has already factored in the company’s future prospects.
Price-to-Earnings of 25.8x: Is it justified?
OMRON currently trades at a price-to-earnings (P/E) ratio of 25.8x, placing it at a premium compared to both its industry peers and its own historical range. With the last close at ¥3,760, investors may be paying a higher price for the prospect of future earnings that exceed market averages.
The price-to-earnings ratio shows how much investors are willing to pay for each yen of OMRON’s earnings. In sectors like industrial automation, a higher P/E can reflect confidence in strong growth or anticipation of long-term profitability.
Compared to the Japanese electronic industry average of 14.8x, OMRON’s P/E is considerably higher. This premium remains even when compared to the peer group’s average of 25.5x and the estimated fair P/E ratio of 23.5x. Such a valuation suggests the market expects OMRON to achieve ambitious profit growth projections, though this is uncertain in a competitive environment.
Explore the SWS fair ratio for OMRON
Result: Price-to-Earnings of 25.8x (OVERVALUED)
However, persistent weak shareholder returns and uncertainty in demand for industrial automation could undermine OMRON’s premium valuation in the future.
Find out about the key risks to this OMRON narrative.
Another View: SWS DCF Model Suggests Even More Downside
Looking at valuation from a different angle, our SWS DCF model estimates OMRON’s fair value at ¥2,762, which is well below the current share price of ¥3,760. This model suggests the stock may actually be overvalued and could put further pressure on the case for a quick recovery. Does this signal heightened risk, or could things change if company growth surprises the market?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out OMRON for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 894 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Build Your Own OMRON Narrative
If you have a different perspective or want to dig deeper into OMRON’s outlook, you can easily build your own investment narrative in just a few minutes. Do it your way.
A great starting point for your OMRON research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
Looking for More Investment Ideas?
Don’t let opportunity pass you by. Supercharge your watchlist today with unique stock ideas you might not have considered yet, right from the Simply Wall Street Screener.
- Capture future growth by checking out these 27 AI penny stocks, which are powering the AI revolution with disruptive innovations and rapid adoption in real-world industries.
- Unlock stable income streams as you browse these 18 dividend stocks with yields > 3%, featuring companies with reliable yields above 3 percent for resilient portfolio building.
- Embrace technological change and see how these 26 quantum computing stocks are making waves in advanced computing for tomorrow’s breakthroughs.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if OMRON might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com